Ambrx Biopharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
La Jolla, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Ambrx Biopharma, Inc. has filed 77 SEC EDGAR filings since 25 Aug 2023

SEC filing history

Showing 51-75 of 77 matching filings.

Per page
25
Current page
3
EFFECT File 333-275053

EFFECT filing

Filing date
02 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-94206

SC 13G

Filing date
02 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-94206

SC 13G filing

Filing date
02 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
01 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-56600

144 filing

Filing date
01 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
31 Oct 2023
Reporting date
27 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
31 Oct 2023
Reporting date
27 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-56600

144 filing

Filing date
27 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Oct 2023
Reporting date
23 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
25 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
24 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-275053

S-3

Filing date
17 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-274952

S-8

Filing date
12 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-271966-01

S-8 POS

Filing date
12 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-271005-01

S-8 POS

Filing date
12 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-264490-01

S-8 POS

Filing date
12 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-257264-01

S-8 POS

Filing date
12 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K12G3 File 000-56600

8-K12G3

Filing date
12 Oct 2023
Reporting date
11 Oct 2023
Next action
Verify source filing
EFFECT File 333-274230

EFFECT filing

Filing date
15 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-274230

424B3

Filing date
15 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
13 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .